We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Anteris Technologies is a medical devices business based in Australia. Anteris Technologies shares (AVR) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Anteris Technologies has a trailing 12-month revenue of around $7.8 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Overall broker
Our top pick for
Low-cost broker
| 52-week range | $7.35 - $30.89 |
|---|---|
| 50-day moving average | $20.4292 |
| 200-day moving average | $15.1738 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.089 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$27.6
| 1 week (2022-06-28) | -8.00% |
|---|---|
| 1 month (2022-06-03) | 22.67% |
| 3 months (2022-04-05) | 52.49% |
| 6 months (2022-01-05) | 119.05% |
| 1 year (2021-07-05) | 272.47% |
|---|---|
| 2 years (2020-07-03) | 430.77% |
| 3 years (2019-07-01) | inf% |
| 5 years (2017-07-05) | -4.83% |
| Revenue TTM | $7.8 million |
|---|---|
| Gross profit TTM | $6.2 million |
| Return on assets TTM | -68.26% |
| Return on equity TTM | -273.43% |
| Profit margin | -294.02% |
| Book value | 1.293 |
| Market capitalisation | $381.3 million |
TTM: trailing 12 months
We're not expecting Anteris Technologies to pay a dividend over the next 12 months.
Anteris Technologies's shares were split on a 1:100 basis on 2 March 2020. So if you had owned 100 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Anteris Technologies shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Anteris Technologies shares which in turn could have impacted Anteris Technologies's share price.
Over the last 12 months, Anteris Technologies's shares have ranged in value from as little as $7.35 up to $30.89. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Anteris Technologies's is 0.8352. This would suggest that Anteris Technologies's shares are less volatile than average (for this exchange).
Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
Steps to owning and managing Kincora Copper shares.
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
Steps to owning and managing Arcadia Minerals shares.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
